Infection with enterotoxigenic Escherichia coli is a leading cause of traveler's diarrhea (1). Many pathogenic human enterotoxigenic E. coli strains secrete ST, a heat-stable small cysteine-rich peptide toxin that binds to the intestinal receptor guanylyl cyclase C known as STaR. The binding of ST to this receptor activates the intracellular guanylyl cyclase domain of the receptor, causing substantial increases in the intracellular cGMP content (2-4). Secretory diarrheal symptoms are believed to result from cross-activation of protein kinase A by cGMP, which in turn stimulates chloride secretion (5-7).
STaR exists as an oligomer in both the presence and the absence of toxin. We also demonstrate that deletion of the intracellular kinase-homology domain produces a constitutively active mutant, suggesting that this domain subserves an autoinhibitory function. Finally, we constructed a point mutant within a highly'conserved region of the cyclase domain that completely inactivates the catalytic activity of guanylyl cyclase. Cotransfection of this point mutant with fwild-type receptor causes a dominant-negative effect on receptor activation. This suggests that interaction of receptor subunits is required for toxin-induced activation and that the cyclase domain is involved in this essential interaction. We propose that the binding of ST to STaR promotes a conformational change across the cell membrane. This removes the inhibitory effects of the kinase-homology domain and promotes an interaction between cyclase domains that leads to receptor activation. The data suggest a paradigm of signal transduction that may also be relevant to other members of the guanylyl cyclase receptor family.
Infection with enterotoxigenic Escherichia coli is a leading cause of traveler's diarrhea (1) . Many pathogenic human enterotoxigenic E. coli strains secrete ST, a heat-stable small cysteine-rich peptide toxin that binds to the intestinal receptor guanylyl cyclase C known as STaR. The binding of ST to this receptor activates the intracellular guanylyl cyclase domain of the receptor, causing substantial increases in the intracellular cGMP content (2) (3) (4) . Secretory diarrheal symptoms are believed to result from cross-activation of protein kinase A by cGMP, which in turn stimulates chloride secretion (5) (6) (7) .
STaR is a member of the guanylyl cyclase receptor family. The intestinal peptide guanylin is the putative endogenous receptor ligand (6, (8) (9) (10) . Other members of this receptor family include the atrial natriuretic peptide (ANP) receptors (GC-A and GC-B), the retinal-specific guanylyl cyclase, and the sea-urchin sperm guanylyl cyclase (11) . Though the receptors regulate diverse physiologic processes through the second messenger cGMP, they have a similar cellular topology. This includes an N-terminal extracellular ligand-binding domain, a single transmembrane domain, a kinase-homology domain,
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (3) into the Xho I and Pst I sites of pME18S (12), a simian virus 40-based expression vector. Epitope-tagged receptors (13) were prepared by inserting the influenza hemagglutinin (HA; YPYDVPDYA) or FLAG (DYKDDDDK) epitope immediately C-terminal to the putative signal sequence cleavage site using PCR (14) . To were transiently transfected with wt-STaR and/or mutant constructs using DEAE-dextran (15) . Guanylyl Cyclase Stimulation Assays. Synthetic ST (STlb) was prepared using fluoren-9-ylmethoxycarbonyl chemistry as described (16) . Cells transfected with either wt-STaR or mutant constructs were split into six-well plates. Forty-eight to 72 h later, cells were stimulated with ST, and extracts were then prepared as described (8) . Samples were acetylated and analyzed for cGMP concentration by RIA (Biomedical Technologies, Stoughton, MA).
Coimmunoprecipitation and Western Blotting. Forty-eight hours after cotransfection, cells in 100-mm plates were washed twice with PBS and lysed in 1 ml of cold lysis buffer [20 mM Hepes, pH 7.5/250 mM NaCl/1% Triton X-100/1% sodium deoxycholate/aprotinin (20 j.g/ml)]. After a 10-min incubation at 4°C, lysates were clarified by centrifugation, and supernates were incubated for 1 h at 4°C with 8 ,g of anti-HA monoclonal antibody (mAb) (clone 12CA5; Boehringer Mannheim). Protein A-Sepharose CL-4B (Pharmacia) was then added for an additional hour (50 ,ul of 50% suspension) to precipitate the immune complexes. Protein A beads were washed four times with cold lysis buffer. The immunoprecipitated samples were heated at 75°C for 5 min in 40 ,u of SDS sample buffer. Samples were analyzed by Western blot with anti-HA (8 ,ug/ml) or anti-FLAG M2 (20 ,ug/ml; IBI) mAb; followed by ECL detection (Amersham).
RESULTS
Functional Activity of Cytoplasmic Deletion Mutants. The kinase-homology domain of STaR is a 310-aa region that is interposed between the transmembrane and guanylyl cyclase domains. It has weak homology to the protein kinase consensus sequence but lacks both the invariant lysine and the nucleotide-binding motif that are essential for protein kinase activity (17, 18) . The functional role of the kinase-homology domain of STaR is unknown. To determine whether it participates in the regulation of signaling, a deletion mutant (kin-) was prepared, and the effects of this deletion on receptor signaling were tested. The deletion mutant was transiently expressed in COS cells, and the recombinant proteins were then analyzed for guanylyl cyclase activity in both the presence and absence of ST. wt-STaR was transfected in parallel as a positive control, and equivalent levels of the expressed recombinant wt-STaR ("135 kDa) and kin-("100 kDa) proteins were confirmed by Western blot (data not shown). Cells transfected with wt-STaR produced low quantities of cGMP (0.4 ± 0.2 pmol/mg), which were comparable to those of vector-transfected cells (Fig. 1 ). After stimulation with saturating concentrations of ST (4 ,uM) ( Fig. 1) , wt-STaR transfectants showed an "90-fold increase in intracellular concentrations of cGMP (34.8 ± 6.6 pmol/mg), consistent with previously published studies (3) . When the kin-mutant was expressed in COS cells, levels of cGMP were high in the absence of ST (34.3 ± 6.0 pmol/mg) and could not be further increased by incubation with toxin (35.6 ± 6.2 pmol/mg). This indicates that guanylyl cyclase in the kin-mutants is constitutively activated, resulting in a ligand-independent production of cGMP that is equal in magnitude to that seen for the maximally stimulated wt-STaR. Thus, the kinase-homology domain has an autoinhibitory effect on guanylyl cyclase activity; its removal mimics the effects of ligand stimulation.
The effects of other large deletions of the cytoplasmic domains on ligand-induced signaling are shown in Fig. 1 To facilitate our study of these potential oligomeric interactions, we inserted HA and FLAG epitope tags into the N-termini of wt-STaR and mutant receptor cDNAs. Both HAand FLAG-wt-STaR constructs had similar affinities (EC5o) and efficacies (Vmax) as the unmodified wt-STaR; intracellular cGMP levels increased "90-fold in the presence of 1 ,uM ST, and the EC50 value for this response was ""150 nM ST. Epitope-tagged kin-constructs showed the same constitutive activity as the original kin-mutant. Having established that these N-terminal modifications do not affect the cellular expression or pharmacologic properties of STaR, we proceeded to use these constructs to study receptor-receptor interactions through cotransfection strategies. Proc. NatL Acad ScL USA 92 (1995) To determine whether the receptor forms oligomeric complexes, we cotransfected COS cells with equimolar quantities of FLAG-and HA-wt-STaR. Cells were lysed and immunoprecipitated using anti-HA mAb. Equal samples of the immunoprecipitates were analyzed by Western blot ( Fig. 2A) probed with either anti-FLAG M2 or anti-HA mAb (positive control). The specificity of these immunoprecipitated proteins was verified using controls in which the anti-HA mAb was preincubated with HA peptide prior to immunoprecipitation (Fig.  2 A-C, peptide +) . Western blot with anti-FLAG mAb revealed a specific band of -135 kDa, indicating that the full-length receptors do physically interact. These data also demonstrate that the cellular receptor exists in an oligomeric state in the absence of ligand and that exposure to toxin does not alter the ratio of oligomeric forms.
The data of Fig. 2A suggest that ligand treatment does not change the proportion of aggregated receptors. To further address this question, we used epitope-tagged kin-mutants, which are in a constitutively activated state. We hypothesized that coimmunoprecipitation studies would yield a negative result if a monomeric or dissociated state were required for cyclase activation. We cotransfected the HA-and FLAG-kinmutants and subjected them to coimmunoprecipitation to test whether these receptors were aggregated. These results shown in Fig. 2B indicate that like wt-STaR, the kin-mutants physically interact in a ligand-independent fashion, demonstrating that the kinase-homology domain is not required for oligomerization.
Next, we asked whether a molecule lacking the cyclase domain (cyc-) was capable of oligomerization to wt-STaR. Ligand-independent coimmunoprecipitation of the cyc-and wt-STaR is observed (Fig. 2C) , indicating that these proteins can interact. cyc-mutants are also able to form homooligomers (data not shown). In contrast, FLAG-ecd, a truncated receptor consisting only of the extracellular and transmembrane domains with a small cytoplasmic tail, failed to coimmunoprecipitate with wt-STaR (data not shown). Thus, the individual domains do not appear to interact with the fulllength receptor. There is sufficient interaction, however, when the extracellular and kinase-homology domains are in cis to promote a physical interaction between these receptor mutants. It therefore seems likely that oligomerization of the STaR is the result of interactions in multiple domains (Fig. 2) .
Demonstration of a Dominant-Negative Phenotype. The above studies established that oligomerization of STaR is a ligand-independent process and that there are several regions within the receptor molecule that facilitate this self- (Fig. 2) , these were not sufficient to produce a dominant-negative effect.
We next hypothesized that interaction within the cyclase domain could be important for receptor activation. Recently, Yuen et at (19) (Fig. 3A) .
Having now established that there is interaction between wt-STaR and the catalytically inactive mutant D834A, we asked whether this interaction interferes with ST-induced cyclase activation, to produce a dominant-negative phenotype. Control cells cotransfected with wt-STaR and a 2-fold excess of empty vector were activated -50-fold in the presence of 185 nM ST (QEC75). Cotransfection with a 2-fold excess of D834A inhibited ST-mediated cyclase activation by a factor of 2.5. Cotransfection with a 3-fold excess of D834A more effectively inhibited ST-induced cyclase activation by a factor of -8 (Fig.  3B) . In experiments using a 1:10 ratio of wt-STaR/D834A, 5 ,uM ST induced only a 2.9-fold increase in cGMP, as compared to 30.3-fold for wt-STaR/vector-transfected controls, representing -11-fold inhibition. Similar results were obtained in the presence of 185 nM and 1 ,uM ST, further supporting a dominant-negative effect (data not shown). Immunoprecipitation with anti-HA mAb confirmed equal expression of HA-wt-STaR when cotransfected with either vector or FLAG-D834A (Fig. 3 C) . Excess expression of the FLAG-D834A was confirmed with anti-FLAG mAb using the same methodology (data not shown). Thus, the dominant-negative phenotype of D834A suggests that at least two functional catalytic domains are required for ligand-induced activation. The results of the above cotransfection experiments are summarized in Table 2 .
DISCUSSION
The guanylyl cyclase receptors are a diverse family of transmembrane receptors found in mammals as well as in lower eukaryotes. These receptors have distinct ligand specificities, and, accordingly, they regulate diverse physiological processes through ligand-specific production of intracellular cGMP. STaR is predominantly localized to the mammalian intestinal epithelium (16, 20) ; the diarrheal disease associated with enterotoxigenic E. coli infection results from toxin-mediated activation of the receptor.
In this report we begin to elucidate the molecular mechanisms leading to signal transduction by STaR. We show that deletion of the kinase-homology domain of STaR leads to constitutive, ligand-independent production of cGMP, equivalent to that of a maximally stimulated receptor. This indicates that the domain has an autoinhibitory effect on receptor function. Elegant studies by Chinkers and Garbers (21) (22) (23) (24) . Radiation inactivation data suggest that STaR is a heterotrimer made up of two full-length monomers plus an N-terminal proteolytic fragment (25) . Our coimmunoprecipitation studies in COS cells reveal only a single band of -135 kDa and suggest that the receptor is a homooligomer, as has been proposed for GC-A (22, 23) . Using coimmunoprecipitation, we have demonstrated an interaction between cyc-and wt-STaR. Despite this interaction, a dominant-negative phenotype was not ob- tOligomerization was determined by cotransfection with equimolar amounts of HA and FLAG epitope-tagged receptor followed by coimmunoprecipitation as described in Methods. (26, 27) . In vitro translation studies are needed to further elucidate the stoichiometry and functional significance of these intermolecular interactions.
We prepared a point mutant at Asp-834 (D834A), a residue that is highly conserved in all guanylyl cyclases. This aspartic acid to alanine mutation abolishes toxin-mediated cyclase activation and produces a dominant-negative phenotype when coexpressed with wt-STaR. These data suggest that the cyclase domain is the critical region for functional interaction of receptor subunits. Yuen et al (19) have recently demonstrated that a mutation of a homologous residue in the a subunit of nitric oxide-sensitive guanylyl cyclase also exerts a dominantnegative effect on activation of the a1/,31 heterodimer. Our findings suggest that despite the structural and functional differences between STaR and the soluble cyclase, both require at least two functional catalytic domains for activation.
One mechanism for the dominant-negative effect may be related to the requirement of a shared catalytic site (19) 
